Manon Veraart News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Manon veraart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Manon Veraart Today - Breaking & Trending Today
SPRINGFIELD, Mass. and ZUG, Switzerland, May 19, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company, has signed a worldwide license agreement with. ....
Western New England University and Quercis Pharma Sign Exclusive Worldwide License Agreements prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article ZUG, Switzerland, May 4, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces that it has entered into a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for the protocol titled, A Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial Comparing, Relative to Placebo, the Effect of Isoquercetin on Thromboembolic Events in Patients with Metastatic Pancreatic Cancer (CATIQ P3). Isoquercetin, the Company s lead product candidate, employs a novel pathway that is based on a new mechanism of action to prevent or reverse thrombus formation with a profile that potentially conveys substantially lowered bleeding risk compared to current standard of care. These mechanisms are related to key thrombotic pathways, including the inhibition of soluble P-selectin, which is known to help prevent ....
Quercis Announces Executive Leadership Appointments Proven life science entrepreneurs from COMPASS Pathways appointed to key operational roles News provided by Share this article Share this article ZUG, Switzerland, April 13, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces the appointment of several new executives to the Company s leadership team. John Boghossian, former Vice President of Operations at COMPASS Pathways, will join Quercis as Chief Executive Officer; Manon Veraart, former Vice President of Business Development at COMPASS Pathways, will join as Chief Business Officer. In addition, Thomas Pfeiffer, Ph.D., former Senior Researcher at University College London, will join as Director of Pipeline Projects. Ilias Läber, Ph.D., the current Chief Executive Officer at Quercis, will transition out of his operational role by end of April 2021 and ....